Inhibition of Human α-Methylacyl CoA Racemase (AMACR): a Target for Prostate Cancer
作者:Andrew J. Carnell、Ralph Kirk、Matthew Smith、Shane McKenna、Lu-Yun Lian、Robert Gibson
DOI:10.1002/cmdc.201300179
日期:2013.8.8
The enzyme α‐methylacyl CoA racemase (AMACR) is involved in the metabolism of branched‐chain fatty acids and has been identified as a promising therapeutic target for prostate cancer. By using the recently available human AMACR from HEK293 kidney cell cultures, we tested a series of new rationally designed inhibitors to determine the structural requirements in the acyl component. An N‐methylthiocarbamate
α-甲基酰基辅酶A外消旋酶(AMACR)参与支链脂肪酸的代谢,已被确定为前列腺癌的有希望的治疗靶标。通过使用最近从HEK293肾细胞培养物中获得的人AMACR,我们测试了一系列新的合理设计的抑制剂,以确定酰基成分的结构要求。一种N-甲基硫代氨基甲酸酯(K i = 98 n M),旨在模拟拟议的酶结合的烯醇酸酯,被发现是迄今为止报道的最有效的AMACR抑制剂。